Sertraline plus deanxit to treat patients with depression and anxiety in chronic somatic diseases: a randomized controlled trial

BACKGROUND: Patients in chronic somatic diseases are often accompanied with depression and anxiety, remission of which may be observed in the third or fourth week after applying common antidepressant medications. We investigate the efficacy and safety of sertraline plus deanxit on patients with depr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Psychiatry
Asıl Yazarlar: Wang, Limin, Zhong, Zhuoyuan, Hu, Jingyang, Rong, Xiaoming, Liu, Jun, Xiao, Songhua, Liu, Zhonglin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4403889/
https://ncbi.nlm.nih.gov/pubmed/25879863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-015-0449-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller